These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15817699)

  • 1. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture.
    Kim MP; Zhou M; Wahl LM
    J Leukoc Biol; 2005 Jul; 78(1):195-201. PubMed ID: 15817699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms.
    Zhang Y; McCluskey K; Fujii K; Wahl LM
    J Immunol; 1998 Sep; 161(6):3071-6. PubMed ID: 9743373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes.
    Ardans JA; Economou AP; Martinson JM; Zhou M; Wahl LM
    J Leukoc Biol; 2002 Jun; 71(6):1012-8. PubMed ID: 12050187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2.
    Zhang Y; Wahl LM
    J Leukoc Biol; 2006 Jan; 79(1):105-13. PubMed ID: 16244112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
    Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
    J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
    Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
    J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
    Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
    Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
    J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
    Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
    Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism.
    Kim MP; Gaydos CA; Wood BJ; Hardick JP; Zhang Y; Wahl LM
    Infect Immun; 2005 Jan; 73(1):632-4. PubMed ID: 15618206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF priming of human monocytes is dependent on ERK1/2 activation.
    Lendemans S; Rani M; Selbach C; Kreuzfelder E; Schade FU; Flohé S
    J Endotoxin Res; 2006; 12(1):10-20. PubMed ID: 16420740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles.
    Baranov D; Armstead WM
    Eur J Pharmacol; 2005 Nov; 525(1-3):112-6. PubMed ID: 16256981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
    Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A
    Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
    J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II induces MMP-2 in a p47phox-dependent manner.
    Luchtefeld M; Grote K; Grothusen C; Bley S; Bandlow N; Selle T; Strüber M; Haverich A; Bavendiek U; Drexler H; Schieffer B
    Biochem Biophys Res Commun; 2005 Mar; 328(1):183-8. PubMed ID: 15670768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
    J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
    Heidinger M; Kolb H; Krell HW; Jochum M; Ries C
    Biol Chem; 2006 Jan; 387(1):69-78. PubMed ID: 16497166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.